These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14028214)

  • 21. Sensory evoked potentials in adult-onset progressive spastic paraparesis.
    Seyal M; Pedley TA
    N Y State J Med; 1984 Feb; 84(2):68-71. PubMed ID: 6583560
    [No Abstract]   [Full Text] [Related]  

  • 22. Investigation of the peripheral vasodilating action of Mydocalm.
    Kusztos D
    Ther Hung; 1965; 13(4):136-8. PubMed ID: 5864158
    [No Abstract]   [Full Text] [Related]  

  • 23. [Modification of the clonus and T-reflex potential by myotonolytica in consideration of the effect of Jendrassik's maneuver. Electromyographic studies in spastic paralysis].
    Reichel G; Stahl J
    Wien Z Nervenheilkd Grenzgeb; 1972; 30(1):25-31. PubMed ID: 4260928
    [No Abstract]   [Full Text] [Related]  

  • 24. Vasodilator effect of intraarterial Mydocalm in dog.
    Keller L; Molnár G; Zulik R
    Ther Hung; 1965; 13(4):139-40. PubMed ID: 5864159
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of lioresal in therapy of spastic paralysis].
    Huffmann G; Fasshauer K; Giesen R
    Med Klin; 1973 Mar; 68(11):340-4. PubMed ID: 4691982
    [No Abstract]   [Full Text] [Related]  

  • 26. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The treatment of trismus with special reference to the myotonolytic drug Mydocalm Richter].
    Elze P
    Dtsch Stomatol; 1966 Nov; 16(11):836-42. PubMed ID: 5225214
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiple sclerosis. Treatment.
    Champion de Crespigny JV
    Aust Fam Physician; 1979 Feb; 8(2):163-8. PubMed ID: 426733
    [No Abstract]   [Full Text] [Related]  

  • 29. Mortality from three chronic nervous diseases, disseminated sclerosis, epilepsy and paralysis agitans.
    ROBERTSON W
    Health Bull (Edinb); 1949 Jan; 7(1):20-2. PubMed ID: 18123324
    [No Abstract]   [Full Text] [Related]  

  • 30. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity].
    Ladd HW; Gingras G; Boucher J; Kazdan N; Keenan R
    Union Med Can; 1973 May; 102(5):1087-92. PubMed ID: 4576244
    [No Abstract]   [Full Text] [Related]  

  • 31. [Muscle tonus in rigidity and spasticity].
    Safronov VA; Vasin NIa; Talambum EA
    Zh Vopr Neirokhir Im N N Burdenko; 1978; (5):27-33. PubMed ID: 716746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Mydocalm on blood flow of the extremities.
    Solti F; Iskum M; Rév I; Nagy I
    Ther Hung; 1965; 13(4):141-3. PubMed ID: 5864160
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical trial of baclofen against placebo.
    Hudgson P; Weightman D; Cartlidge NE
    Postgrad Med J; 1972 Oct; 48():Suppl 5:37-40. PubMed ID: 4585729
    [No Abstract]   [Full Text] [Related]  

  • 34. [Familial spastic spinal paralysis: a family report].
    KOBAYASHI T; MIYASAKA M; FUKUMIZU Y
    No To Shinkei; 1963 May; 15():475-80. PubMed ID: 14033943
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential diagnosis of paralysis agitans.
    Baxter DW
    Prim Care; 1977 Sep; 4(3):429-39. PubMed ID: 264220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic indications in spasticity symptoms of multiple sclerosis].
    Lebrun C
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1045-50. PubMed ID: 11787335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Spastic paresis of the arms and flaccid paralysis of the legs in secondary progressive multiple sclerosis].
    Jacksch C; Paschen S; Peters S; Lindner V; Berg D
    Nervenarzt; 2021 Oct; 92(10):1061-1063. PubMed ID: 33709169
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent advance in the study of multiple sclerosis.
    Igata A
    Tokai J Exp Clin Med; 1986; 11 Suppl():171-7. PubMed ID: 2898174
    [No Abstract]   [Full Text] [Related]  

  • 39. [Kinetometric demonstration of the antispastic action of a GABA derivative (Ciba 34647-BA)].
    Mutani R; Fariello R; Quattrocolo G; Delsedime M
    Riv Neurol; 1971; 41(3):143-51. PubMed ID: 5126431
    [No Abstract]   [Full Text] [Related]  

  • 40. The evaluation of imipramine in the treatment of Parkinson's disease.
    GILLHESPY RO; MUSTARD DM
    Br J Clin Pract; 1963 Apr; 17():205-8. PubMed ID: 13947924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.